Baker Bros. Advisors LP Revolution Medicines, Inc. Transaction History
Baker Bros. Advisors LP
- $9.86 Billion
- Q2 2025
A detailed history of Baker Bros. Advisors LP transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 9,364,972 shares of RVMD stock, worth $551 Million. This represents 3.49% of its overall portfolio holdings.
Number of Shares
9,364,972
Previous 7,936,972
17.99%
Holding current value
$551 Million
Previous $281 Million
22.76%
% of portfolio
3.49%
Previous 3.34%
Shares
7 transactions
Others Institutions Holding RVMD
# of Institutions
341Shares Held
195MCall Options Held
908KPut Options Held
723K-
Vanguard Group Inc Valley Forge, PA15.8MShares$928 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA14.3MShares$843 Million2.37% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$789 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X010.6MShares$623 Million0.2% of portfolio
-
Wellington Management Group LLP Boston, MA10.3MShares$604 Million0.07% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $5.16B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...